9 Reasons to Buy Pfizer in 2018 and 1 Big One Not To Post author:Sam Post published:December 21, 2017 Post category:BioPharma Pfizer may be the surprise strong-growth stock for next year. Source: BioSpace You Might Also Like Bay Area's Dynavax Quietly Shops Around Its Almost-Approved Hep B Vaccine October 1, 2017 Booming Celltrion Falls After FDA Warning Letter January 31, 2018 Strike It Rich With These 3 Biotech Stocks That Have Late-Stage Drugs April 10, 2017
